Carter BloodCare - Arlington FDA Record
Carter BloodCare - Arlington has 0 FDA recalls, 7 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Carter BloodCare - Arlington" is on file.
- Latest inspection
- May 15, 2025 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 7 | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Carter BloodCare - Arlington as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Carter BloodCare - Arlington yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| May 15, 2025 | Arlington, TX | Biologics | No Action Indicated (NAI) | 1677509 |
| Oct 17, 2019 | Arlington, TX | Biologics | No Action Indicated (NAI) | 1677509 |
| May 17, 2018 | Arlington, TX | Biologics | No Action Indicated (NAI) | 1677509 |
| Sep 15, 2016 | Arlington, TX | Biologics | No Action Indicated (NAI) | 1677509 |
| Apr 23, 2014 | Arlington, TX | Biologics | No Action Indicated (NAI) | 1677509 |
| Jul 18, 2012 | Arlington, TX | Biologics | No Action Indicated (NAI) | 1677509 |
| Jul 13, 2010 | Arlington, TX | Biologics | No Action Indicated (NAI) | 1677509 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 1677509 | Arlington, TX | 7 | May 15, 2025 |
Carter BloodCare - Arlington and the FDA: common questions
Has Carter BloodCare - Arlington received an FDA warning letter?
No FDA warning letter addressed to the name "Carter BloodCare - Arlington" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Carter BloodCare - Arlington received an FDA Form 483?
FDA has not published a Form 483 for "Carter BloodCare - Arlington" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Carter BloodCare - Arlington?
The most recent FDA inspection on file ended May 15, 2025 at Arlington, TX and was classified NAI. FDA has 7 inspections of Carter BloodCare - Arlington on file.
Need more than this page shows? Ask about Carter BloodCare - Arlington in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.